SCHEMBL41864

SCHEMBL41864

C=C(C)C(=O)OC(C)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.53
HPGD P15428 1/20 0.46
ELANE P08246 1/20 0.44
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 1/20 0.42
TP53 P04637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 1/20 0.40
FFAR1 O14842 1/20 0.40
RORC P51449 2/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
ATM Q13315 1/20 0.39
LPAR1 Q92633 2/20 0.39
LPAR3 Q9UBY5 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907558 1.00 HCAR2 (0.53) HCAR2HPGDELANEALDH1A1CYP3A4
Ethylene Glycol SCHEMBL6490841 0.93 HCAR2 (0.47) HCAR2HPGDELANEALDH1A1CYP3A4
SCHEMBL14258939 0.90 TSHR (0.41) HCAR2HPGDELANEALDH1A1TP53
SCHEMBL9159588 0.86 HCAR2 (0.44) HCAR2HPGDELANEALDH1A1CYP3A4
SCHEMBL8088686 0.86 HCAR2 (0.61) HCAR2ALDH1A1CYP3A4TP53HSD17B10
SCHEMBL17511150 0.86 ALDH1A1 (0.42) HCAR2HPGDELANEALDH1A1CYP3A4
SCHEMBL28116999 0.86 LMNA (0.46) HCAR2ELANEALDH1A1FFAR1LMNA
SCHEMBL29351716 0.85 HCAR2 (0.44) HCAR2HPGDELANEALDH1A1CYP3A4
SCHEMBL20481632 0.85 CYP2C9 (0.38) HCAR2HPGDALDH1A1KMT2ALMNA
SCHEMBL16085915 0.85 HCAR2 (0.56) HCAR2HPGDALDH1A1CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12611296-B2 Intraocular lens materials and components ALCON INC. (CH) 2026-04-28 US claimed
EP-3962413-B1 A NEW ADVANCED FORMULATION FOR HYDROPHOBIC INTRAOCULAR LENSES AND THEIR PRODUCTION METHOD VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) 2026-04-08 EP claimed
EP-4043396-B1 REDUCED POROUS GRAPHENE OXIDE, MANUFACTURING METHOD THEREFOR, SULFUR-CARBON COMPOSITE COMPRISING SAME, AND LITHIUM SECONDARY BATTERY LG ENERGY SOLUTION LTD (KR) 2025-09-24 EP claimed
CN-119431642-A Resin particle composition, detection kit, and method for producing resin particle composition 赛登化学株式会社 2025-02-14 CN claimed
US-20250043103-A1 RESIN PARTICLE COMPOSITION, TEST KIT, AND MANUFACTURING METHOD OF RESIN PARTICLE COMPOSITION SAIDEN CHEMICAL INDUSTRY CO., LTD. (JP) 2025-02-06 US claimed
EP-4501971-A1 RESIN PARTICLE COMPOSITION, TEST KIT, AND MANUFACTURING METHOD OF RESIN PARTICLE COMPOSITION Saiden Chemical Industry Co., Ltd. (JP) 2025-02-05 EP claimed
CN-119019599-A Polymer and preparation method and application thereof 湖南朗昇医疗科技有限公司 2024-11-26 CN claimed
US-20240350256-A1 INTRAOCULAR LENS MATERIALS AND COMPONENTS ALCON INC. (CH) 2024-10-24 US claimed
US-12059342-B2 Intraocular lens materials and components ALCON INC. (CH) 2024-08-13 US claimed
US-20240142665-A1 OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2024-05-02 US claimed
EP-0674684-A1 POLYMERISABLE YELLOW DYES AND THEIR USE IN OPHTHALMIC LENSES ALCON LABORATORIES, INC. (US) 1995-10-04 EP claimed
WO-1995011279-A1 POLYMERISABLE YELLOW DYES AND THEIR USE IN OPHTHALMIC LENSES ALCON LABORATORIES, INC. (US) 1995-04-27 WO claimed
US-5406641-A Acrylate core mixture crosslinkable with coextruded fluoro-polymer; heat resistant, good hardness ROHM AND HAAS COMPANY (US) 1995-04-11 US claimed
US-5378763-A Radiation transparent, melt processability, heat resistance ENICHEM S.P.A. (IT) 1995-01-03 US claimed
EP-0629493-A1 A cured composite and a process for producing the cured composite ROHM AND HAAS COMPANY (US) 1994-12-21 EP claimed
US-5258355-A Graft polymer with unsaturated ester groups forming shells AGFA-GEVAERT AKTIENGESELLSCHAFT 1993-11-02 US claimed
EP-0465064-A2 Resist and process for forming patterns using the same FUJITSU LIMITED (JP) 1992-01-08 EP claimed
EP-0158357-B1 METHOD OF FORMING RESIST MICROPATTERN NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) 1991-02-27 EP claimed
US-4717759-A WITH AROMATIC ACRYLATES; ELECTRICAL INSULATION NIPPON PETROCHEMICALS CO., LTD. (JP) 1988-01-05 US claimed
US-4620954-A Hydrogel from ultraviolet-initiated copolymerization CIBA VISION CARE CORP. (US) 1986-11-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12611296-B2 Intraocular lens materials and components CRYAA, AQP4, CRYZ HCAR2 1670/4885HPGD 1164/4885ELANE 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.